KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Other Operating Expenses (2017 - 2024)

Historic Other Operating Expenses for Bionano Genomics (BNGO) over the last 5 years, with Q4 2024 value amounting to $138000.0.

  • Bionano Genomics' Other Operating Expenses fell 8137.65% to $138000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $138000.0, marking a year-over-year decrease of 9951.25%. This contributed to the annual value of $27.7 million for FY2024, which is 6449.03% down from last year.
  • According to the latest figures from Q4 2024, Bionano Genomics' Other Operating Expenses is $138000.0, which was down 8137.65% from $21.3 million recorded in Q3 2024.
  • Bionano Genomics' 5-year Other Operating Expenses high stood at $77.3 million for Q3 2023, and its period low was $138000.0 during Q4 2024.